糖尿病骨质疏松症的研究进展:综合性综述
1School of Clinical Medicine, Shandong Second Medical University, Weifang, China.
Frontiers in endocrinology
|September 18, 2025
概括
糖尿病骨质疏松症 (DOP) 管理需要针对血糖和骨健康的综合疗法. 本综述探讨了糖尿病药物和骨质疏松症药物如何协同工作,改善糖尿病骨质疏松症患者的治疗结果.
科学领域:
- 内分泌学 在内分泌学.
- 代谢性骨疾病 代谢性骨疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病骨质疏松症 (DOP) 是糖尿病的一种并发症,其特点是骨质不佳和骨折风险增加.
- 高血糖,胰岛素抵抗和骨代谢变化是导致DOP的关键因素.
- 需要综合治疗策略,以解决血糖控制和骨完整性问题.
研究的目的:
- 系统地审查降血糖和骨保护剂在治疗糖尿病骨质疏松症中的分子机制.
- 突出这些药物在解决DOP的代谢和骨方面的双重作用.
- 探索组合疗法的潜在协同效应和风险.
主要方法:
- 对现有文献进行系统审查.
- 对DOP的病理生理路径的分析,包括胰岛素/IGF-1缺乏,AGE,氧化应激和血管损伤.
- 对抗糖尿病药物 (甲福明,GLP-1RA,SGLT2抑制剂) 和抗骨质疏松药物 (双酸盐,酸,酸) 的作用机制的检查.
主要成果:
- DOP涉及高血糖,胰岛素抵抗和骨代谢之间的复杂相互作用.
- 抗糖尿病药物和抗骨质疏松症药物具有可以影响骨健康的机制.
- 协同效应的潜力存在,但必须考虑与联合疗法相关的风险.
结论:
- 开发新疗法和优化组合疗法对于DOP的双重代谢和骨效益至关重要.
- 综合管理策略对于改善患者的治疗结果至关重要.
- 需要进一步的研究,以充分阐明组合治疗的治疗潜力.
相关概念视频
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Pathophysiology of Diabetes
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Bone Disorders
5.1K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.1K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K


